Why the study?
Does immunization with cardiac troponin I exacerbate myocardial inflammation and cardiac dysfunction in mice following myocardial infarction or ischaemia reperfusion injury?
Does immunization with cardiac troponin I exacerbate myocardial inflammation and cardiac dysfunction in mice following myocardial infarction or ischaemia reperfusion injury?
Autoimmunity against cardiac troponin I exacerbates myocardial inflammation and cardiac dysfunction following both chronic myocardial infarction and ischaemia/reperfusion injury in a mouse model.
Answers are grounded in this paper and cite their sources.
cTnI autoimmunity worsens post-IR dysfunction in mice; hypothesis-generating for human MI inflammation, needs clinical validation.
AIMS: Autoimmunity against cardiac troponin I (cTnI) has deleterious effects on the infarcted myocardium early after onset of ischaemia. Here, we explored the impact of cTnI-autoimmunity in the long term. Furthermore, we studied the effects of cTnI-autoimmunity on the infarcted myocardium following revascularization measures in terms of ischaemia reperfusion injury (IRI), which resembles clinical reality more closely. METHODS AND RESULTS: After immunization with either cTnI (n= 10) or a control buffer (n= 14), A/J mice underwent chronic coronary artery ligation. Another group of mice immunized with cTnI (n= 13) underwent temporary coronary artery occlusion and were compared with non-immunized controls (n= 17). Left ventricular function was evaluated by echocardiography. Hearts were obtained for histological evaluation. Immunological responses were quantified by analysis of cytokine and chemokine patterns as well as anti-cTnI antibody titres. Myocardial inflammation and cardiac dysfunction were detectable as late as 180 days after myocardial infarction (MI). Previous cTnI-immunization enhanced myocardial inflammation and dysfunction. Mice subjected to cTnI-immunization before IRI exhibited a higher inflammation score, an upregulated expression of pro-inflammatory chemokines (IP-10, MIP-1, Ltn, RANTES, TCA-3) and chemokine receptors (CCR2, CCR5), increased interleukin (IL)-2, interferon (IFN)-g, and decreased IL-10 production along with a markedly reduced fractional shortening after IRI compared with the controls. CONCLUSION: Our results demonstrate for the first time that cTnI-induced autoimmune response not only leads to increased myocardial inflammation and impaired cardiac function 180 days after chronic coronary artery ligation, but also exacerbates ischaemia/reperfusion injury compared with non-immunized controls. Hence, the presence of cTnI-autoimmunity could render subjects more vulnerable to prospective myocardial injury, be it MI, or secondary revascularization measures.
No takes yet. Share an insight, caveat, or question.
Volz et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: